{
    "name": "Leon-Triana2020 - CAR T-cell therapy in B-cell acute lymphoblastic leukaemia",
    "description": "<notes xmlns=\"http://www.sbml.org/sbml/level2/version4\">      <body xmlns=\"http://www.w3.org/1999/xhtml\">        <pre>This model is based on the publication:\"CAR T cell therapy in B-cell acute lymphoblastic leukaemia: Insights from mathematical models\".Odelaisy León-Triana, Soukaina Sabir, Gabriel F. Calvo, Juan Belmonte-Beitia, Salvador Chulián, Álvaro Martínez-Rubio, María Rosa, Antonio Pérez-Martínez, Manuel Ramirez-Orellana, Víctor M. Pérez-Garcíadoi: 10.1016/j.cnsns.2020.105570 Comment:This model is based on equations (4a)-(4c).Abstract: Immunotherapies use components of the patient immune system to selectively target can- cer cells. The use of chimeric antigenic receptor (CAR) T cells to treat B-cell malignancies –leukaemias and lymphomas–is one of the most successful examples, with many patients experiencing long-lasting full responses to this therapy. This treatment works by extract- ing the patient’s T cells and transducing them with the CAR, enabling them to recognize and target cells carrying the antigen CD19 + , which is expressed in these haematological cancers. Here we put forward a mathematical model describing the time response of leukaemias to the injection of CAR T cells. The model accounts for mature and progenitor B-cells, leukaemic cells, CAR T cells and side effects by including the main biological processes involved. The model explains the early post-injection dynamics of the different compart- ments and the fact that the number of CAR T cells injected does not critically affect the treatment outcome. An explicit formula is found that gives the maximum CAR T cell ex- pansion in vivo and the severity of side effects. Our mathematical model captures other known features of the response to this immunotherapy. It also predicts that CD19 + cancer relapses could be the result of competition between leukaemic and CAR T cells, analogous to predator-prey dynamics. We discuss this in the light of the available evidence and the possibility of controlling relapses by early re-challenging of the leukaemia cells with stored CAR T cells.</pre>      </body>    </notes>",
    "format": {
        "name": "SBML",
        "identifier": "SBML",
        "version": "L2V4"
    },
    "publication": {
        "type": "DOI",
        "accession": "10.1016/j.cnsns.2020.105570",
        "journal": "Communications in Nonlinear Science and Numerical Simulation",
        "title": "CAR T cell therapy in B-cell acute lymphoblastic leukaemia: Insights from mathematical models",
        "affiliation": "a Department of Mathematics, Mathematical Oncology Laboratory (MOLAB), Universidad de Castilla-La Mancha, Ciudad Real, Spain\nb Faculty of Sciences, University Mohammed V, Rabat, Morocco\nc Department of Mathematics, Universidad de Cádiz, Biomedical Research and Innovation Institute of Cádiz (INiBICA), Hospital Universitario Puerta del Mar, Cádiz, Spain\nd Translational Research Unit in Paediatric Haemato-Oncology, Haematopoietic Stem Cell Transplantation and Cell Therapy, Hospital Universitario La Paz, Madrid, Spain\ne Paediatric Haemato-Oncology Department, Hospital Universitario La Paz, Madrid, Spain\nf Department of Paediatric Haematology and Oncology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain",
        "synopsis": "Immunotherapies use components of the patient immune system to selectively target can- cer cells. The use of chimeric antigenic receptor (CAR) T cells to treat B-cell malignancies –leukaemias and lymphomas–is one of the most successful examples, with many patients experiencing long-lasting full responses to this therapy. This treatment works by extract- ing the patient’s T cells and transducing them with the CAR, enabling them to recognize and target cells carrying the antigen CD19 + , which is expressed in these haematological cancers. Here we put forward a mathematical model describing the time response of leukaemias to the injection of CAR T cells. The model accounts for mature and progenitor B-cells, leukaemic cells, CAR T cells and side effects by including the main biological processes involved. The model explains the early post-injection dynamics of the different compart- ments and the fact that the number of CAR T cells injected does not critically affect the treatment outcome. An explicit formula is found that gives the maximum CAR T cell ex- pansion in vivo and the severity of side effects. Our mathematical model captures other known features of the response to this immunotherapy. It also predicts that CD19 + cancer relapses could be the result of competition between leukaemic and CAR T cells, analogous to predator-prey dynamics. We discuss this in the light of the available evidence and the possibility of controlling relapses by early re-challenging of the leukaemia cells with stored CAR T cells.",
        "year": 2020,
        "month": "3",
        "volume": "94",
        "pages": "105570",
        "link": "http://identifiers.org/doi/10.1016/j.cnsns.2020.105570",
        "authors": [
            {
                "name": "Odelaisy Leon-Triana"
            },
            {
                "name": "Soukaina Sabir"
            },
            {
                "name": "Gabriel F. Calvo"
            },
            {
                "name": "Juan Belmonte-Beitia"
            },
            {
                "name": "Salvador Chulian"
            },
            {
                "name": "Alvaro Martinez-Rubio"
            },
            {
                "name": "Maria Rosa"
            },
            {
                "name": "Antonio Perez-Martinez"
            },
            {
                "name": "Manuel Ramirez-Orellana"
            },
            {
                "name": "Victor M. Perez-Garcia"
            }
        ]
    },
    "files": {
        "main": [
            {
                "name": "Leon-Triana2020 (eqs 4).xml",
                "description": "SBML level 2 version 4 representation of the model",
                "fileSize": "31366",
                "mimeType": "application/xml",
                "md5sum": "092f19ebbb6135386ed6321064ebbdab",
                "sha1sum": "d7e15bbfcfc58a4aa89bc855f9a6014954b3cac7",
                "sha256sum": "2bef6c9d398c2e0563d175ecf394e25eb12efbeea889ed0d4ed47b81cce93a84"
            }
        ],
        "additional": [
            {
                "name": "Leon-Triana2020 (eqs 4)-biopax2.owl",
                "description": "Auto-generated BioPAX (Level 2) file.",
                "fileSize": "11915",
                "mimeType": "application/rdf+xml",
                "md5sum": "cfab1e1ed7f137d1c62132fe529eb6a0",
                "sha1sum": "1c363f3ab3f5f56bb50d339702a06ab6b8aea771",
                "sha256sum": "2dbdfb465bd5a87da5f406adba7ac15142061385999420632452c52bf0b2021c"
            },
            {
                "name": "Leon-Triana2020 (eqs 4)-biopax3.owl",
                "description": "Auto-generated BioPAX (Level 3) file.",
                "fileSize": "14933",
                "mimeType": "application/rdf+xml",
                "md5sum": "8e965af3c011523210143f52c8158a94",
                "sha1sum": "88ace856d2da4bda9adbad5a6a8f81cb0ae85e6e",
                "sha256sum": "3805dd4d51f24082086014b6447cdcfacb2593d5468d38edf7cb84f3326d6102"
            },
            {
                "name": "Leon-Triana2020 (eqs 4)-matlab.m",
                "description": "Auto-generated Matlab file.",
                "fileSize": "4554",
                "mimeType": "text/x-matlab",
                "md5sum": "fe7faca3d5ffdb68ef8194932ea8a1e1",
                "sha1sum": "3dfb352f4a5a3efc9ab99d743f064eac10f6b3e3",
                "sha256sum": "63a684a6bc2f6a772af3dacbdfda394c394418a4a6dd69a86045ab690abf6ddd"
            },
            {
                "name": "Leon-Triana2020 (eqs 4)-octave.m",
                "description": "Auto-generated Octave file.",
                "fileSize": "4554",
                "mimeType": "text/x-matlab",
                "md5sum": "8f18568d224bb66bbec7a4b4b909ed29",
                "sha1sum": "7d41e1b377e888a0558c314592767f669f02525e",
                "sha256sum": "fbb28149ac9eeec8585f3f5475fd83c201ddfeb0acc4cc8b4932516efaef7b69"
            },
            {
                "name": "Leon-Triana2020 (eqs 4).cps",
                "description": "COPASI file",
                "fileSize": "58714",
                "mimeType": "application/xml",
                "md5sum": "10a86159975d8c2ee47ec7e14aeec0c3",
                "sha1sum": "df98e4ca3afe01b412e6047e1c5213035bd90129",
                "sha256sum": "58f493faa045e4f330c332d0af6fddb2d470162dceac5d5ebd372fc0bd90dad8"
            },
            {
                "name": "Leon-Triana2020 (eqs 4).ode",
                "description": "Auto-generated ODE file for XPP.",
                "fileSize": "2997",
                "mimeType": "text/plain",
                "md5sum": "4e0f604801e45cd9e39e43ceac33cbcf",
                "sha1sum": "58b181c50eb85bf39b584dc9a44dc696c8e5c20f",
                "sha256sum": "2d77b34829bb80184233daaf117bc170e90191d57c6e74a113bbbd77ecb3b9c5"
            },
            {
                "name": "Leon-Triana2020 (eqs 4).sedml",
                "description": "SEDML file (additionally CRBM-validated and adjusted).",
                "fileSize": "11156",
                "mimeType": "application/xml",
                "md5sum": "9774b00718a2ba2118661c0c2c710a30",
                "sha1sum": "584d162d39b2c8a2a1508b9cdb2bb88e52385a93",
                "sha256sum": "4a98937023551b8505bca393360da93dc223605cfa088830f68fbec6f55cb615"
            },
            {
                "name": "curation_image.png",
                "description": "Reproduced figure(s) from original curation.",
                "fileSize": "123164",
                "mimeType": "image/png",
                "md5sum": "dd9ae9742ea066847bd07992ec609da8",
                "sha1sum": "47e0126b882c92cb09035a486a4be4f34a315bf1",
                "sha256sum": "e65e49a5f69cd27f467c639103776dd39948162b4f2de0403a8bb825b02dcd95"
            },
            {
                "name": "curation_notes.txt",
                "description": "Notes from original curation (describes curation_image).",
                "fileSize": "121",
                "mimeType": "text/plain",
                "md5sum": "4b4cffa7d8ce4b506a1892ed06e0527c",
                "sha1sum": "7ebddae187cf8b902d35343f7c8a9eb1a759da4e",
                "sha256sum": "c1c5508f61191b01b256b9270da98e9355293321f22bfbd2e146fea2ba2bcd50"
            },
            {
                "name": "manifest.xml",
                "description": "Auto-generated manifest file for OMEX archives.",
                "fileSize": "1515",
                "mimeType": "application/xml",
                "md5sum": "7b97af0de4d4a54547633fb3beee9ca1",
                "sha1sum": "45fbc920023c8f1b1fdce7863933571a70791b78",
                "sha256sum": "7f97abf0a81d17c014deb8a03b850b2ffde377ed4ff3d5504f0590ed52549def"
            },
            {
                "name": "metadata.rdf",
                "description": "Auto-generated annotation metadata file.",
                "fileSize": "3884",
                "mimeType": "application/rdf+xml",
                "md5sum": "35a0d1da584995b5e46296c09b7d710a",
                "sha1sum": "5ffcd5eef16d5b359ed680c5e32386fad105c425",
                "sha256sum": "4392ad7f1ac25f64f6c61f132d1dd6c03744951529e8d4ea9531510a20870316"
            }
        ]
    },
    "history": {
        "revisions": [
            {
                "version": 2,
                "submitted": 1626104957,
                "submitter": "Emilia Chen",
                "comment": "Automatically added model identifier BIOMD0000001011"
            },
            {
                "version": 4,
                "submitted": 1626169417,
                "submitter": "Emilia Chen",
                "comment": "Automatically added model identifier BIOMD0000001011"
            },
            {
                "version": 5,
                "submitted": 1724291663,
                "submitter": "Lucian Smith",
                "comment": "CRBM-sponsored manual and automated updates."
            }
        ]
    },
    "firstPublished": 1725282013,
    "submissionId": "MODEL2107120001",
    "publicationId": "BIOMD0000001011",
    "modellingApproach": {
        "accession": "MAMO_0000046",
        "name": "ordinary differential equation model",
        "resource": "http://identifiers.org/mamo/MAMO_0000046"
    },
    "curationStatus": "CURATED",
    "modelTags": [
        "Immuno-oncology"
    ],
    "contributors": {
        "Curator": [
            {
                "name": "Lucian Smith",
                "email": "lpsmith@uw.edu",
                "affiliation": "University of Washington",
                "orcid": "0000-0001-7002-6386",
                "external": false
            }
        ],
        "Modeller": [
            {
                "name": "Emilia Chen",
                "email": "emiliachen1@gmail.com",
                "affiliation": "University of Cambridge",
                "external": false
            }
        ]
    },
    "vcsIdentifier": "aaj",
    "modelLevelAnnotations": [
        {
            "qualifier": "bqbiol:hasTaxon",
            "accession": "9606",
            "name": "Homo sapiens",
            "resource": "Taxonomy",
            "uri": "http://identifiers.org/taxonomy/9606"
        },
        {
            "qualifier": "bqbiol:hasProperty",
            "accession": "MAMO_0000046",
            "name": "Ordinary differential equation model",
            "resource": "Mathematical Modelling Ontology",
            "uri": "http://identifiers.org/mamo/MAMO_0000046"
        },
        {
            "qualifier": "bqbiol:hasProperty",
            "accession": "C15262",
            "name": "Immunotherapy",
            "resource": "NCIt",
            "uri": "http://identifiers.org/ncit/C15262"
        },
        {
            "qualifier": "bqbiol:hasProperty",
            "accession": "NCIT:C126102",
            "name": "Chimeric Antigen Receptor T-Cell Therapy",
            "resource": "NCIt",
            "uri": "http://identifiers.org/ncit/C126102"
        },
        {
            "qualifier": "bqmodel:is",
            "accession": "BIOMD0000001011",
            "resource": "BioModels Database",
            "uri": "http://identifiers.org/biomodels.db/BIOMD0000001011"
        },
        {
            "qualifier": "bqmodel:is",
            "accession": "MODEL2107120001",
            "resource": "BioModels Database",
            "uri": "http://identifiers.org/biomodels.db/MODEL2107120001"
        },
        {
            "qualifier": "bqmodel:isDescribedBy",
            "accession": "10.1016/j.cnsns.2020.105570",
            "resource": "DOI",
            "uri": "https://identifiers.org/doi:10.1016/j.cnsns.2020.105570"
        },
        {
            "qualifier": "bqbiol:occursIn",
            "accession": "BTO:0000089",
            "name": "blood",
            "resource": "Brenda Tissue Ontology",
            "uri": "http://identifiers.org/bto/BTO:0000089"
        },
        {
            "qualifier": "bqbiol:isDescribedBy",
            "accession": "10.1016/j.cnsns.2020.105570",
            "resource": "DOI",
            "uri": "http://identifiers.org/doi/10.1016/j.cnsns.2020.105570"
        },
        {
            "qualifier": "bqbiol:hasProperty",
            "accession": "HP:0004812",
            "name": "B Acute Lymphoblastic Leukemia",
            "resource": "Human Phenotype Ontology",
            "uri": "http://identifiers.org/hp/HP:0004812"
        },
        {
            "qualifier": "bqbiol:hasProperty",
            "accession": "GO:0002376",
            "name": "immune system process",
            "resource": "Gene Ontology",
            "uri": "http://identifiers.org/go/GO:0002376"
        },
        {
            "qualifier": "bqbiol:hasProperty",
            "accession": "DOID:1037",
            "name": "lymphoid leukemia",
            "resource": "Human Disease Ontology",
            "uri": "http://identifiers.org/doid/DOID:1037"
        }
    ]
}